Fri, 19 Jan 2018 19:21:18: New clues to T cell development could boost search for HIV vaccine

Fri, 19 Jan 2018 14:48:42: Broad Institute knocked back by European CRISPR patent ruling

Fri, 19 Jan 2018 13:31:15: Ablynx investor opens door to Novo deal at a higher price

Fri, 19 Jan 2018 09:44:59: Heptares, Sosei shuffle leadership as CSO Marshall departs

Fri, 19 Jan 2018 08:26:49: Chutes & Ladders—Pandion emerges with Pfizer, Biogen veterans as leaders

Thu, 18 Jan 2018 17:57:09: Switching off enzymes to block cell division in cancer

Thu, 18 Jan 2018 14:46:37: Gilead/Kite team up with Pfizer for CAR-T-mAb combination

Thu, 18 Jan 2018 10:59:19: Inositec names ex-Roche, Novartis staffer as CMO

Wed, 17 Jan 2018 15:08:35: Scientists reveal secrets of ‘anti-aging’ hormones

Wed, 17 Jan 2018 13:28:33: China's Innovent eyeing IPO this year—and could list in U.S.

Wed, 17 Jan 2018 09:20:42: Retooling drug development with next-generation machine learning, Owkin nabs $11M

Wed, 17 Jan 2018 08:48:53: Juno stock jumps as reports suggest Celgene wants a buyout

Wed, 17 Jan 2018 08:19:41: FDA chief Gottlieb backs away from plan to publish CRLs

Tue, 16 Jan 2018 14:26:48: In conversation with: Sarepta CEO Doug Ingram

Tue, 16 Jan 2018 13:56:57: AveXis steps up gene therapy pursuit of Biogen’s SMA pathfinder

Tue, 16 Jan 2018 13:51:49: Eiger writes off ubenimex in PAH after total flop in phase 2

Tue, 16 Jan 2018 13:15:38: Pherecydes raises cash to trial anti-infective phage therapies

Tue, 16 Jan 2018 11:34:44: Merck KGaA taps CRUK, ICR for source of cancer candidates

Tue, 16 Jan 2018 08:47:54: U.K. seeks to help startups by easing access to samples, data and disease models

Mon, 15 Jan 2018 14:17:22: Message to Trump: Alnylam CEO proud to be a ‘shitholer’

Mon, 15 Jan 2018 12:45:44: Hikma names ex-Fresenius scientist as global R&D chief

Mon, 15 Jan 2018 10:22:43: Biofrontera files for IPO to run skin cancer clinical trials

Fri, 12 Jan 2018 16:28:50: Fresh insights into a giant protein could improve heart health

Fri, 12 Jan 2018 14:00:45: Concert rethinks R&D plans after loss in Incyte patent case

Fri, 12 Jan 2018 13:19:04: Forty Seven lines up Roche as second partner for CD47 cancer immunotherapy